Skip to main content
SpringerLink
Log in

Cutaneous T-Cell Lymphoma

  • Chapter
  • First Online:
Clinical Cases in Skin of Color

Part of the book series: Clinical Cases in Dermatology ((CLIDADE))

  • 1072 Accesses

Abstract

A 31-year-old Black male presented with a 10-year history of a diffuse pruritic rash. He was initially diagnosed with pityriasis rosea and reported complete resolution of the eruption. However, a similar rash recurred eight years later. An alternative medicine specialist had prescribed an oral anti-fungal and later topical steroid without resolution.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agi C, Kuhn D, Chung J, Zampella J, Hinds G. Racial differences in the use of extracorporeal photopheresis for mycosis fungoides. J Dermatol Treat. 2015;26(3):266–8.

    Google Scholar 

  • Apisarnthanarax N, Talpur R, Ward S, Ni X, Kim HW, Duvic M. Tazarotene 0.1 % gel for refractory mycosis fungoides lesions: an open-label pilot study. J Am Acad Dermatol. 2004;50(4):600–7.

    Article  PubMed  Google Scholar 

  • Arulogun S, Prince HM, Gambell P, Lade S, Ryan G, Eaton E, et al. Extracorporeal photopheresis for the treatment of Sezary syndrome using a novel treatment protocol. J Am Acad Dermatol. 2008;59(4):589–95.

    Article  PubMed  Google Scholar 

  • Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chinn DM, Chow S, Kim YH, Hoppe RT. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Int J Radiat Oncol Biol Phys. 1999;43(5):951–8.

    Article  CAS  PubMed  Google Scholar 

  • Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143(7):854–9.

    Article  PubMed  Google Scholar 

  • Dummer R, Quaglino P, Becker JC, Hasan B, Karrasch M, Whittaker S, et al. Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. J Clin Oncol. 2012;30(33):4091–7.

    Article  CAS  PubMed  Google Scholar 

  • Duvic M, Talpur R, Wen S, Kurzrock R, David CL, Apisarnthanarax N. Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma. Clin Lymphoma Myeloma. 2006;7(1):51–8.

    Article  CAS  PubMed  Google Scholar 

  • Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, et al. Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma. Clin Lymphoma Myeloma. 2009;9(6):412–6.

    Article  PubMed  Google Scholar 

  • Duvic M, Dummer R, Becker JC, Poulalhon N, Ortiz Romero P, Grazia Bernengo M, et al. Panobinostat activity in both bexarotene-exposed and -naive patients with refractory cutaneous T-cell lymphoma: results of a phase II trial. Eur J Cancer. 2013;49(2):386–94.

    Article  CAS  PubMed  Google Scholar 

  • Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med. 1987;316(6):297–303.

    Article  CAS  PubMed  Google Scholar 

  • Foss F, Horwitz SM, Coiffier B, Bartlett N, Popplewell L, Pro B, et al. Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study. Clin Lymphoma Myeloma Leuk. 2012;12(4):238–43.

    Article  CAS  PubMed  Google Scholar 

  • Herrmann JJ, Roenigk Jr HH, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol. 1995;33(2 Pt 1):234–42.

    Article  CAS  PubMed  Google Scholar 

  • Hinds GA, Heald P. Cutaneous T-cell lymphoma in skin of color. J Am Acad Dermatol. 2009;60(3):359–75; quiz 76–8.

    Article  PubMed  Google Scholar 

  • Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205 e1–16; quiz 21–2.

    Article  Google Scholar 

  • Kuzel TM, Roenigk Jr HH, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, et al. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome. J Clin Oncol. 1995;13(1):257–63.

    Article  CAS  PubMed  Google Scholar 

  • Leboit P, Burg G, Weedon D, Sarasin A. Pathology and genetics: skin tumors. Lyons: IARC Press; 2006.

    Google Scholar 

  • Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, et al. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02 %, gel in mycosis fungoides. JAMA Dermatol. 2013;149(1):25–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Molin L, Thomsen K, Volden G, Groth O, Hellbe L, Holst R, et al. Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian Mycosis Fungoides Study Group. Acta Derm Venereol. 1980;60(6):542–4.

    CAS  PubMed  Google Scholar 

  • Morales-Suarez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guenel P, Arveux P, et al. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). Cancer Causes Control. 2005;16(10):1253–9.

    Article  PubMed  Google Scholar 

  • Navi D, Riaz N, Levin YS, Sullivan NC, Kim YH, Hoppe RT. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides. Arch Dermatol. 2011;147(5):561–7.

    Article  PubMed  Google Scholar 

  • Oguz O, Engin B, Aydemir EH. The influence of psoralen + ultraviolet A treatment on the duration of remission and prognosis in mycosis fungoides. J Eur Acad Dermatol Venereol. 2003;17(4):483–5.

    Article  CAS  PubMed  Google Scholar 

  • Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9(5):1089–107.

    CAS  PubMed  Google Scholar 

  • Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, et al. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys. 2013;85(3):747–53.

    Article  PubMed  Google Scholar 

  • Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266–81.

    Article  CAS  PubMed  Google Scholar 

  • Willemze R. Cutaneous T-cell lymphoma. In: Bolognia J, Jorizzo J, Rapini R, editors. Dermatology. 2. 2nd ed. Spain: Mosby Elsevier; 2008. p. 1867–86.

    Google Scholar 

  • Wongpraparut C, Setabutra P. Phototherapy for hypopigmented mycosis fungoides in Asians. Photodermatol Photoimmunol Photomed. 2012;28(4):181–6.

    Article  PubMed  Google Scholar 

  • Zackheim HS, Kashani-Sabet M, Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol. 1998;134(8):949–54.

    Article  CAS  PubMed  Google Scholar 

  • Zackheim HS, Kashani-Sabet M, McMillan A. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol. 2003;49(5):873–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Johns Hopkins Medicine, Baltimore, MD, USA

    Chikoti M. Wheat MD & Ginette A. Okoye MD

Authors
  1. Chikoti M. Wheat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ginette A. Okoye MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chikoti M. Wheat MD .

Editor information

Editors and Affiliations

  1. Montgomery Dermatology, PC, Montgomery, Alabama, USA

    Porcia B. Love

  2. Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

    Roopal V. Kundu

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wheat, C.M., Okoye, G.A. (2016). Cutaneous T-Cell Lymphoma. In: Love, P., Kundu, R. (eds) Clinical Cases in Skin of Color. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-23615-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23615-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23614-8

  • Online ISBN: 978-3-319-23615-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation